In an environment under increasing pressure on prices, increasing competitiveness is a prime focus for the healthcare industry.
Medical device manufacturers are now confronted by new entrants to the market, increasingly agile, with a strong capacity to innovate and a service-oriented approach. To regain the upper hand, legacy players in the medical device industry must identify new sources of competitiveness. Their path to success includes Design-to-Cost and digitalization, to cut down costs and imagine new added-value services (personalized medicine).
Pharma companies must adapt their research and innovation to embrace the ongoing transition from chemistry to life sciences. To achieve this goal, they need to adjust their organization and capture relevant acquisition opportunities. As in all changing environments, these industry players must adapt their OPEX to improve their production units’ profitability (digitalization, industry 4.0, etc.).
AVENCORE has an outstanding track record of leading winning transformation programs in the healthcare industry: investment optimization, change in operating model, integration and alignment of strategic partners.